Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
115.24
+3.06 (2.73%)
Mar 5, 2026, 4:00 PM EST - Market closed
Celcuity Market Cap
Celcuity has a market cap or net worth of $5.33 billion as of March 6, 2026. Its market cap has increased by 1,025.43% in one year.
Market Cap
5.33B
Enterprise Value
5.20B
1-Year Change
1,025.43%
Ranking
Category
Stock Price
$115.24
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $5.33B, an increase of 3,882.30%. That is a compound annual growth rate of 54.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 5.19B | 12.47% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cogent Biosciences | 5.96B |
| CRISPR Therapeutics AG | 5.76B |
| Mirum Pharmaceuticals | 5.61B |
| Caris Life Sciences | 5.61B |
| Immunovant | 5.51B |
| Scholar Rock Holding | 5.45B |
| PTC Therapeutics | 5.32B |
| CG Oncology | 5.20B |